Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study to Investigate the Efficacy, Safety, and Tolerability of Six Weeks Treatment With V565 in Subjects With Active Crohn's Disease

NCT02976129 is registered in ClinicalTrials.gov with VHsquared Ltd. as lead sponsor.

NCT NCT02976129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02976129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study to Investigate the Efficacy, Safety, and Tolerability of Six Weeks Treatment With V565 in Subjects With Active Crohn's Disease
Lead sponsor
VHsquared Ltd.
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2016
Completion date
March 8, 2019
Enrollment
125 (actual)
Sites
94

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease